Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03739606 |
Title | Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | City of Hope Medical Center |
Indications | |
Therapies | |
Age Groups: | adult | child | senior |
Covered Countries |